探索基于CRISPR/Cas9的基因编辑的帕金森相关激酶:超越α-synuclein
Heba M Mansour1, Aiman S El-Khatib2
1Central Administration of Biological, Innovative Products, and Clinical Studies, Egyptian Drug Authority, EDA, Giza, Egypt.
Ageing research reviews
|November 4, 2023
概括
CRISPR/Cas9基因编辑通过向酶失调为帕金森病 (PD) 治疗提供了一个有前途的策略. 本综述探讨了CRISPR/Cas9对PD相关激酶的应用以及未来的研究方向.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元损失和运动障碍.
- 家族性PD与SNCA,PINK1,LRRK2和DJ-1等基因的突变有关.
- 激酶失调与PD病变发生有关.
研究的目的:
- 审查CRISPR/Cas9基因组编辑系统的结构,功能和历史.
- 要总结参与CRISPR/Cas9.9准的PD病原发生的酶.
- 探索新的激酶标,并解决PD研究中的CRISPR/Cas9挑战.
主要方法:
- 审查CRISPR/Cas9技术及其在PD研究中的应用.
- 鉴定和总结CRISPR/Cas9针对的PD相关激酶 (例如LRRK2,PINK1).
- 讨论潜在的新酶标和CRISPR/Cas9非标效应.
主要成果:
- 克里斯普尔/卡斯9技术是神经退行性疾病研究的一个快速发展的工具.
- 目前有几种激酶 (LRRK2,PINK1,PKC-γ,AMPK) 是PD的目标.
- 新的目标包括GRK,GAK,CDK5,ATM,c-ABL和RET受体.
结论:
- 克里斯普尔/Cas9技术在推动PD研究方面具有重大潜力.
- 基因编辑与基因治疗一起,为帕金森病提供了一个有前途的治疗策略.
- 解决非目标效应和挑战对于PD中有效的CRISPR/Cas9应用至关重要.
相关概念视频
CRISPR/Cas9 Genome Editing
17
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
17
CRISPR
51.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.9K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


